About Arimizole Tablet
Capitalise on the inestimable efficacy of Arimizole Tablet, a sought-after laureate in hormone antagonist therapy. Available in 1x10 tablets strip, this oral prescription-only medication features Anastrozole (Arimidex) 1 mg, renowned for its highly selective aromatase inhibition in postmenopausal breast cancer treatment. The white to off-white, odorless tablets are expertly designed for ease of use and marked by industry-leading standards. For a limited time, benefit from exclusive markdown opportunities. Store below 30C and protect from light or moisture to optimise shelf life and effectiveness.
Directions, Application Areas & Recommended Administration
Arimizole Tablet is indicated for postmenopausal women battling breast cancer. Administered orally, the tablets are to be used strictly under medical supervision, as directed by a qualified physician. The site of application is systemic, via oral ingestion. It is not suitable for premenopausal women or those allergic to Anastrozole. Consistent compliance with prescribed dosage enhances its effectiveness in inhibiting estrogen production crucial for certain cancer treatments.
Supply Ability, Export Markets & Certifications
We offer Arimizole Tablet across extensive markets, with robust supply ability ensuring timely fulfillment. India remains our main export hub, catering to global demands with accredited, high-quality standards. Our certifications guarantee compliance, while efficient expenditure management minimises freight fees, providing optimal value. Partners can trust in seamless logistics and official documentation, fostering reliable international and domestic trade of this essential medication.
FAQ's of Arimizole Tablet:
Q: How should Arimizole Tablet be administered?
A: Arimizole Tablet should be taken orally, exactly as prescribed by your physician. Do not exceed or reduce the dosage without consulting your healthcare provider.
Q: What is the main benefit of using Arimizole Tablet for breast cancer treatment?
A: Arimizole Tablet inhibits the aromatase enzyme, thereby blocking estrogen production, which is a key therapeutic approach in treating estrogen receptor-positive breast cancer in postmenopausal women.
Q: When is Arimizole Tablet contraindicated?
A: The use of Arimizole Tablet is contraindicated in premenopausal women and individuals with a known allergy to Anastrozole.
Q: Where should Arimizole Tablet be stored to maintain efficacy?
A: Store Arimizole Tablet in a cool, dry place below 30C, protected from light and moisture, to ensure maximum shelf life and effectiveness.
Q: What is the shelf life and supply format of Arimizole Tablet?
A: Arimizole Tablet comes in a 1x10 tablets strip with a shelf life of 24 months when stored as recommended.
Q: How does Arimizole Tablet exert its therapeutic action?
A: Arimizole acts as a highly selective, non-steroidal aromatase inhibitor, which lowers estrogen levels by blocking the aromatase enzyme, essential for certain breast cancer treatments.